Diabetes mellitus produces abnormalities of the endothelium and impair
s endothelium-dependent dilatation of large and small cerebral blood v
essels. However, the effect of diabetes mellitus on cerebral vasoconst
riction and the modulatory influence of nitric oxide on cerebral vasoc
onstriction is unclear. Thus, the first goal of this study was to exam
ine the effect of diabetes mellitus on constrictor responses of the ba
silar artery in vivo. Our second goal was to examine a potential role
for nitric oxide in modulating constrictor responses of the basilar ar
tery. A craniotomy was performed over the ventral medulla to expose th
e basilar artery. The diameter of the basilar artery was measured usin
g intravital microscopy in nondiabetic and diabetic (3-4 months after
injection of streptozotocin; 50-60 mg/kg i.p.) rats in response to ang
iotensin II, arginine vasopressin, endothelin-l, and the thromboxane a
nalogue, U-46619. Topical application of angiotensin II (10 and 100 nM
) produced only minimal changes in diameter of the basilar artery whic
h were similar in nondiabetic and diabetic rats (p > 0.05). Arginine v
asopressin (0.1 and 1.0 nM), endothelin-l (10 and 50 nM), and U-46619
(10 and 100 nM) produced marked dose-related constriction of the basil
ar artery which also was similar in nondiabetic and diabetic rats (p >
0.05). Next, we examine whether the synthesis/release of nitric oxide
played a role in constriction of the basilar artery in response to th
e agonists. Vile found that L-NMMA (1.0 mu M) did not alter constricto
r responses of the basilar artery in nondiabetic and diabetic rats. Th
us, responses of the basilar artery to important vasoactive agonists a
re not altered by diabetes mellitus. In addition, it does not appear t
hat the synthesis/release of nitric oxide modulates constrictor respon
ses of the basilar artery to angiotensin II, arginine vasopressin, end
othelin-l and U-46619. We suggest that preservation of vasoconstrictor
responses, coupled with impaired vasodilator responses, may contribut
e to the pathogenesis of cerebrovascular abnormalities associated with
diabetes mellitus. (C) 1998 Elsevier Science B.V.